IHI vs NLR: Holdings Overlap & Returns
Over the year to Nov 13, 2026, IHI returned −7.4% to NLR's −30.3%; 0% of their weight is in the same names.
- Return gap
- +22.9 pts1 year to Nov 13, 2026: IHI ahead, total return
- Fee gap
- 0.15 ptsA year: IHI 0.37%, NLR 0.52%, per filings dated Apr 29, 2026 and Jul 27, 2026
- Overlap
- 0%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
IHI −7.4%, NLR −30.3%: IHI +22.9 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in IHI costs about $1.00 one way and $2.00 in and out, at a median spread of 0.02%. The 0.02% spread is IHI’s 30-day median, from iShares (fund page).
Fees over time
Hypothetical. $10,000 in NLR for 10 years at 0.52% a year costs about $859 in fees and lost growth; IHI at 0.37% would cost $615. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.
15% of NLR's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.
Key numbers
IHI costs 0.15 points a year less; their one-year returns differ by 22.9 points; IHI is 1.4 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | −7.4% | −30.3% |
|---|---|---|
| Below its all-time high | 11.5%, high on Sep 8, 2021 | 46.2%, high on Jan 28, 2026 |
| What it tracks | Therapeutics and medical devices | Nuclear and uranium |
| Its benchmark, total return, 1 year | +13.1% | |
| Against its benchmark, 1 year | behind by 43.4 pts | |
| Expense ratio | 0.37% | 0.52% |
| Net assets, as of Nov 12, 2026 | $4.0bn | $2.9bn |
| Holdings in common | 0% |
The numbers behind it
Net assets: $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF, and $2.9bn on Nov 12, 2026 for VanEck Uranium and Nuclear ETF.
Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.
What they share
By the books each fund has filed, IHI and NLR hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.
half
0% in common
Only in IHI
Show all 8 holdings
| ABBOTT LABORATORIES | 17.27% |
| INTUITIVE SURGICAL | 14.46% |
| MEDTRONIC PLC | 11.51% |
| IDEXX LABORATORIES | 5.48% |
| EDWARDS LIFESCIENCES | 4.96% |
| BECTON DICKINSON AND CO | 4.85% |
| GE HEALTHCARE TECHNOLOGIES | 4.63% |
| STRYKER | 4.59% |
Only in NLR
Show all 8 holdings
| Cameco Corp | 8.41% |
| Constellation Energy Corp | 8.04% |
| Public Service Enterprise Group Inc | 7.09% |
| BWX Technologies Inc | 6.78% |
| Fortum Oyj | 5.75% |
| Oklo Inc | 5.22% |
| Centrus Energy Corp | 5.05% |
| Uranium Energy Corp | 4.99% |
Side by side
Open the table
| Fund | iShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies | VanEck Uranium and Nuclear ETF · Holds 25 stocks in nuclear and uranium, 15% of its weight in S&P 500 companies |
| Issuer | iShares | VanEck |
| Theme | Therapeutics and medical devices | Nuclear and uranium |
| In the S&P 500 | 88.5% | 15.1% |
| Active share vs the S&P 500 | 98.7% | 99.8% |
| In the Nasdaq-100 | 28.4% | 8.0% |
| Holdings | 51 | 25 |
| Top ten, share of the fund | 76.0% | 61.1% |
| Expense ratio | 0.37% | 0.52% |
| Fee for the differing part | 0.37% | 0.52% |
| Total return, 1 year | −7.4% | −30.3% |
| vs its benchmark | not measured | −43.4 pts vs ACWI |
| Below its high | −11.5% | −46.2% |
| Net assets, IHI as of Nov 13, 2026 and NLR as of Nov 12, 2026 | $4.1bn | $2.9bn |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +4.2% | −25.2% | not measured | −21.4 pts vs ACWI |
|---|---|---|---|---|
| 6 months | +20.1% | −31.8% | not measured | −33.8 pts vs ACWI |
| 1 year | −7.4% | −30.3% | not measured | −43.4 pts vs ACWI |
| 3 years | +23.4% | +29.8% | not measured | −40.4 pts vs ACWI |
| Since launch (Not the same days: IHI May 2006 · NLR Aug 2007) | +658.0% | +53.0% | not measured | not measured |
About IHI
By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.
About NLR
By weight, 15% of NLR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 61% of the fund across 25 positions, as filed for Jun 30, 2026.
More
Over the year to Nov 13, 2026 the fund returned −30.3% with distributions reinvested against +13.1% for its benchmark, the MSCI ACWI Index, so a holder was behind by 43.4 pts. It sits 46.2% below its all-time high of Jan 28, 2026.
0% of the two portfolios are the same securities at the same weight.
Questions people ask
Do IHI and NLR hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, IHI against NLR, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ihi-vs-nlr
ETFIQ. (Nov 13, 2026). IHI against NLR. Retrieved from https://etfiq.com/compare/themes/ihi-vs-nlr
[IHI against NLR (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ihi-vs-nlr)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.